InvestorsObserver
×
News Home

Is Acer Therapeutics Inc (ACER) The Right Choice in Biotechnology?

Wednesday, January 13, 2021 10:34 AM | InvestorsObserver Analysts

Mentioned in this article

Is Acer Therapeutics Inc (ACER) The Right Choice in Biotechnology?

Acer Therapeutics Inc (ACER) is around the top of the Biotechnology industry according to InvestorsObserver. ACER received an overall rating of 57, which means that it scores higher than 57 percent of all stocks. Acer Therapeutics Inc also achieved a score of 68 in the Biotechnology industry, putting it above 68 percent of Biotechnology stocks. Biotechnology is ranked 31 out of the 148 industries.

Overall Score - 57
ACER has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on ACER!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 57 means the stock is more attractive than 57 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Acer Therapeutics Inc Stock Today?

Acer Therapeutics Inc (ACER) stock has gained 9.69% while the S&P 500 is down -0.01% as of 10:31 AM on Wednesday, Jan 13. ACER has gained $0.25 from the previous closing price of $2.58 on volume of 1,069,949 shares. Over the past year the S&P 500 is up 15.77% while ACER is down -32.13%. ACER lost -$2.07 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Acer Therapeutics Inc (ACER) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App